To examine the effect of APC loss on tumor response to immune checkpoint blockade, syngeneic mice were subcutaneously implanted with CT26-WT, CT26-shApc, MC38-WT, or MC38-shApc tumor cells. This evidence concerns the gene DDX53 and neoplasm.